Back to Search
MICHAEL WHITLOW, M.D., PH.D.
M.D., PH.D.
Clinical & Laboratory Dermatological Immunology Physician
NPI: 1669431979Individual
Specialties, Licenses & Credentials
Dermatology Physician
Dermatology
Code: 207N00000X
174606(NY)
Clinical & Laboratory Dermatological Immunology PhysicianPrimary
Dermatology — Clinical & Laboratory Dermatological Immunology
Code: 207NI0002X
174606(NY)
Research & Publications (20)
Potent triazolothione inhibitor of heat-shock protein-90.
PMID 19519743·Chem Biol Drug Des·2009
7-preclinical
The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
PMID 19074424·J Biol Chem·2009
7-preclinical
Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.
PMID 18394906·Bioorg Med Chem·2008
8-other
Structures of potent selective peptide mimetics bound to carboxypeptidase B.
PMID 18219114·Acta Crystallogr D Biol Crystallogr·2008
8-other
Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517.
PMID 17544272·Bioorg Med Chem Lett·2007
8-other
Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
PMID 17536795·J Med Chem·2007
7-preclinical
Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.
PMID 17531483·Bioorg Med Chem Lett·2007
8-other
1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
PMID 17368901·Bioorg Med Chem Lett·2007
7-preclinical
The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase.
PMID 17336523·Bioorg Med Chem Lett·2007
8-other
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.
PMID 17315988·J Med Chem·2007
7-preclinical
Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.
PMID 17227710·Bioorg Med Chem·2007
7-preclinical
3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
PMID 17189688·Bioorg Med Chem Lett·2007
7-preclinical
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
PMID 16585186·Cancer Res·2006
8-other
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.
PMID 16125385·Bioorg Med Chem Lett·2005
8-other
Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase B.
PMID 15982000·Biochemistry·2005
7-preclinical
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.
PMID 15772071·J Biol Chem·2005
7-preclinical
Long-term evaluation of compliance with refuge requirements for Bt cotton.
PMID 15714465·Pest Manag Sci·2005
8-other
A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase.
PMID 15557261·Protein Sci·2004
7-preclinical
Long-term regional suppression of pink bollworm by Bacillus thuringiensis cotton.
PMID 12571355·Proc Natl Acad Sci U S A·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 635 MADISON AVE
NEW YORK, NY 10022 - Phone
- (212) 753-5382
Quick Facts
- NPI
- 1669431979
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile